Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 8 matching records.
8 results — page 1 of 1
- Level CRetrospective StudyEurope PMC
Comparative effectiveness of ustekinumab versus infliximab in the management of perianal fistulizing Crohn's disease: a retrospective study in China
Retrospective Study on Autoimmune Research, published in Intest Res (2026) — summary generated from the PubMed abstract.
- 2026
Intest Res1 citations - Level CCohort StudyPubMed
Real-life effectiveness of allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulizing refractory Crohn's disease.
Cohort Study with a reported sample of 36 on Scar, Autoimmune Research, published in Clin Res Hepatol Gastroenterol (2024) — summary generated from the PubMed abstract.
- 2024
- n = 36
Clin Res Hepatol Gastroenterol - Level CRetrospective StudyPubMed
Evaluation of the Effectiveness and Safety of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease: An International Real-Life Retrospective Multicentre Cohort Study.
Retrospective Study with a reported sample of 223 on Autoimmune Research, published in Aliment Pharmacol Ther (2024) — summary generated from the PubMed abstract.
- 2024
- n = 223
Aliment Pharmacol Ther - Level BClinical TrialPubMed
Predictive modeling to evaluate long-term treatment effectiveness of darvadstrocel in patients with complex perianal fistulas in Crohn's disease.
Clinical Trial with a reported sample of 513 on Autoimmune Research, published in BMC Gastroenterol (2024) — summary generated from the PubMed abstract.
- 2024
- n = 513
BMC Gastroenterol1 citations - Level ASystematic ReviewPubMed
Effectiveness and safety of darvadstrocel in patients with complex perianal fistulizing Crohn's disease: a systematic review.
Systematic Review on Autoimmune Research, published in Ann Gastroenterol (2023) — summary generated from the PubMed abstract.
- 2023
Ann Gastroenterol6 citations - Level BRandomized Controlled TrialPubMed
INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn's Disease Treated in the ADMIRE-CD Trial.
Randomized Controlled Trial on Autoimmune Research, published in Inflamm Bowel Dis (2022) — summary generated from the PubMed abstract.
- 2022
Inflamm Bowel Dis40 citations - Level CProspective StudyPubMed
Effect of Crohn's disease mesenteric mesenchymal stem cells and their extracellular vesicles on T-cell immunosuppressive capacity.
Prospective Study on Immune Modulation, Autoimmune Research, published in J Cell Mol Med (2022) — summary generated from the PubMed abstract.
- 2022
J Cell Mol Med - Level DAnimal StudyPubMed
Mesenteric Adipose-derived Stromal Cells From Crohn's Disease Patients Induce Protective Effects in Colonic Epithelial Cells and Mice With Colitis.
Animal Study on Chronic Inflammation, Autoimmune Research, published in Cell Mol Gastroenterol Hepatol (2018) — summary generated from the PubMed abstract.
- 2018
Cell Mol Gastroenterol Hepatol11 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406